Benitec Biopharma (BNTC) Prices 15.54M Share Offering at $1.93/sh

Go back to Benitec Biopharma (BNTC) Prices 15.54M Share Offering at $1.93/sh

Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering

August 8, 2023 10:30 PM EDT

HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (Benitec or the Company), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference ("ddRNAi") Silence and Replace platform, today announced the pricing of its underwritten public offering of 15,544,041 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying warrants to purchase up to 15,544,041 shares of common stock. Each share of common stock is being sold together with one common warrant to purchase one share of common stock at... More